1-3 of 3
Nisar A. Baig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Resistance to Complement Dependent Cytotoxicity in CLL Cells From Patients Treated with Ofatumumab

Nisar A. Baig, Ronald P. Taylor, PhD, Margaret A. Lindorfer, PhD, Amy K Church, Betsy R. LaPlant, Emily S. Pavey, Tait D. Shanafelt, MD, Timothy G. Call, MD, Neil Kay, MD, Grzegorz S. Nowakowski, MD, Clive S. Zent, MD
Journal: Blood
Blood (2011) 118 (21): 2836.
https://doi.org/10.1182/blood.V118.21.2836.2836
Published: 2011
Journal Articles

Interactions with the Microenvironment Protect Lymphoma B-Cells From Rituximab Induced Apoptosis and Could Represent a Therapeutic Target

Marek Mraz, MD, Clive S. Zent, MD, Amy K Church, Nisar A Baig, Diane F. Jelinek, PhD, Xiaosheng Wu, PhD, Sarka Pospisilova, Dr, PhD, Stephen M. Ansell, MD, PhD, Anne J. Novak, PhD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD
Journal: Blood
Blood (2010) 116 (21): 3115.
https://doi.org/10.1182/blood.V116.21.3115.3115
Published: 2010
Journal Articles

Complement Activation and Cytotoxicity In CLL Cells Treated with Alemtuzumab and Ofatumumab: Evidence for Multiple Mechanisms of Resistance to Complement Dependent Cytotoxicity

Nisar A Baig, Amy K Church, Grzegorz S. Nowakowski, MD, Ronald P Taylor, PhD, Margaret A Lindorfer, PhD, Clive S. Zent, MD
Journal: Blood
Blood (2010) 116 (21): 3575.
https://doi.org/10.1182/blood.V116.21.3575.3575
Published: 2010